Safety, pharmacokinetics, and preliminary activity of the α-specific PI3K inhibitor BYL719: Results from the first-in-human study Meeting Abstract


Authors: Gonzalez-Angulo, A. M.; Juric, D.; Argilés, G.; Schellens, J. H. M.; Burris, H. A.; Berlin, J.; Middleton, M. R.; Schuler, M. H.; Van Geel, R.; Helgason, T.; Bootle, D.; Boehm, M.; Goggin, T. K.; Demanse, D.; Quadt, C.; Baselga, J.
Abstract Title: Safety, pharmacokinetics, and preliminary activity of the α-specific PI3K inhibitor BYL719: Results from the first-in-human study
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419601049
PROVIDER: wos
Notes: Meeting Abstract: 2531 -- Source: Wos
MSK Authors
  1. Jose T Baselga
    394 Baselga